Venture
TMRW Life Sciences, Inc.
Latest Form D 2026-04-24- CIK 1759388
- State NY
- Other Health Care
- 5 Form D offerings since 2019-12-23
- Total sold
- $223M
- across 5 offerings
- Rounds
- 5
- Form D offerings since 2019-12-23
- Latest round
- $38.4M
- 2026-04-24 · 021-581848
- Investors
- 59
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-04-24 · $38.4M
- 2019-12-23$36.5M021-356272
- 2021-02-12$20M021-389284
- 2021-07-15$100M021-406418
- 2024-07-12$28.2M021-518545
- 2026-04-24$38.4M021-581848
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($100M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-581848 | First filed2026-04-24 | Latest2026-04-24 | Sought$38.4M | Sold$38.4M | Investors59 | Exemptions506(b) |
| 021-518545 | First filed2024-07-12 | Latest2024-07-12 | Sought$30M | Sold$28.2M | Investors69 | Exemptions506(b) |
| 021-406418 | First filed2021-07-15 | Latest2022-05-13 | Sought$102M | Sold$100M | Investors59 | Exemptions506(b) |
| 021-389284 | First filed2021-02-12 | Latest2021-02-12 | Sought$20M | Sold$20M | Investors35 | Exemptions506(b) |
| 021-356272 | First filed2019-12-23 | Latest2020-05-19 | Sought$36.5M | Sold$36.5M | Investors34 | Exemptions506(b) |
Who backs TMRW Life Sciences, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-04-24
| Name | Relationship |
|---|---|
| Louis Villalba | RelationshipExecutive Officer, Director |
| Andrew Schwab | RelationshipDirector |
| Vinay Shah | RelationshipDirector |
| William Schoolcraft | RelationshipDirector |
| Jeffrey Port | RelationshipDirector |
| Greg Eisner | RelationshipDirector |
| Emily Drabant Conley | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- New York (NY)
- Exemptions
- Rule 506(b)
- First filed
- 2019-12-23
- Latest filing
- 2026-04-24
Who backs TMRW Life Sciences, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗